| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |